MK0869 (0869-068)

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK0869 (0869-068), covering 2017-05-05 to 2017-05-05. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Patients With Major Depressive Disorder With MK0869 (0869-068)(COMPLETED) [Phase 3]